Please login to the form below
tacrolimus
This page shows the latest tacrolimus news and features for those working in and with pharma, biotech and healthcare.
New study identifies drugs that are safe to use in COVID-19 treatment
The study also found that low doses of prednisolone or tacrolimus therapy could be helpful in the treatment of COVID-19. ... Current evidence suggests that low dose prednisolone (a steroid used to treat allergies) and tacrolimus therapy (an
Latest news
-
CHMP recommends Teva's generic version of Astellas' Advagraf
The Israeli generics manufacturer’s macrolide immunosuppressant medicinal Tacforius (tacrolimus) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) after demonstrating a “satisfactory quality”
-
AbbVie and J&J file first non-cancer use for Imbruvica with FDA
high-dose steroids on top of immunosuppressants like tacrolimus and cyclosporine.
-
Astellas sells dermatology unit to Leo for €675m
Skincare specialist Leo is paying 675m for the product portfolio, which is headed by severe eczema treatment Protopic (tacrolimus), Locoid and Locobase skin creams and acne therapy Zineryt (erythromycin/zinc acetate).
-
Advagraf shows survival increase for liver transplant patients
The study, which comes from the European Liver Transplant Registry (ELTR), found that early use of Advagraf (tacrolimus extended release capsules), a new once-daily formulation of Astellas' immunosuppressant, offers a ... Whilst we do not know the
-
CHMP backs European approval for six new medicines
Envarsus (tacrolimus), its once-daily drug for the prophylaxis and treatment of organ rejection in adult transplant patients.
More from news
Approximately 1 fully matching, plus 21 partially matching documents found.
Latest Intelligence
-
Astellas: Ten years young
diff. Alongside these launches the company has been moving into the oncology arena, adding to its legacy interest in urology from Yamanouchi and Fujisawa, and transplantation, where it has Prograf (tacrolimus)
-
Deal Watch November 2015
The deal includes Protopic (tacrolimus) for severe eczema treatment, skin creams Locoid and Locobase and acne therapy Zineryt (erythromycin/zinc acetate).
-
Pharma deals during October 2012
that is in phase III. LCP-Tacro is a novel formulation of tacrolimus based on Veloxis' MeltDose technology, which enhances the bioavailability of compounds with low water solubility. ... 58. †Veloxis Pharmaceuticals / Chiesi Farmaceutici. Licence.
-
Interview: Ken Jones, Astellas Pharma Europe
In transplantation, three years ago we launched Advagraf, a prolonged-release tacrolimus formulation, which offers the consistency of exposure so vital for transplant recipients.
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Gilead agrees $21bn buyout of Immunomedics
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- Gavi says 76 wealthy countries have committed to COVAX vaccine facility
- Roche’s Ocrevus boasts positive long-term data in MS
- First patients dosed with COVID-19 vaccine from SpyBiotech and Serum Institute of India
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020
- Alone we can do so little, together we can do so much
- What can't we afford to treat anymore?
- OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
PMHub
Nucleus Global
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...
Latest intelligence
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
- 7 important considerations for creating an inclusive clinical trial website
- You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Quick links
Infographics
